The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Arteritic Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis

Vision-threatening optic nerve infarction in temporal arteritis

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Göz Hastalıkları department. Book Appointment →

What is Arteritic Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis?

Giant cell arteritis (GCA) is a granulomatous large-vessel vasculitis affecting individuals over 50 years (mean 70-75 years), with female predominance and association with polymyalgia rheumatica. Inflammatory destruction of the internal elastic lamina and intimal hyperplasia in medium-to-large arteries lead to occlusion. The most devastating ophthalmic complication is arteritic anterior ischemic optic neuropathy (AAION), causing sudden, painless, severe vision loss (often hand motions or worse).

Other ocular manifestations include posterior ischemic optic neuropathy, central retinal artery occlusion, cilioretinal artery occlusion, choroidal infarction, ocular ischemic syndrome, and ocular motor cranial neuropathies. Systemic features include new headache (temporal, severe), jaw claudication (highly specific), scalp tenderness, polymyalgia rheumatica (proximal stiffness), constitutional symptoms (fever, weight loss, night sweats, malaise), and elevated inflammatory markers (ESR > 50, CRP elevated).

Diagnosis combines clinical features (American College of Rheumatology criteria), elevated inflammatory markers, and definitive temporal artery biopsy showing granulomatous inflammation with multinucleated giant cells, internal elastic lamina disruption, and intimal hyperplasia. Vascular ultrasound (halo sign), MRI of cranial vessels, and PET-CT (large vessel involvement) are increasingly used. Immediate high-dose corticosteroids (oral prednisone 1 mg/kg or IV methylprednisolone pulse), tocilizumab (IL-6 receptor blocker), and supportive care are essential to prevent contralateral involvement.

Symptoms

Sudden, painless, severe unilateral vision loss
Hand motions or worse vision typically
Altitudinal visual field defect
Optic disc edema with pallor (chalky white)
Hemorrhages around disc
Cilioretinal artery occlusion
Central retinal artery occlusion
Choroidal infarction
Cranial neuropathies (third, fourth, sixth)
Diplopia
Ocular ischemic syndrome
Anterior segment ischemia
New onset severe headache (temporal, scalp)
Scalp tenderness, especially over temporal artery
Jaw claudication (highly specific)
Tongue claudication
Polymyalgia rheumatica (proximal stiffness, especially morning)
Constitutional symptoms (fever, weight loss, night sweats, malaise)
Aortic involvement (aneurysm, dissection)
Stroke from large vessel involvement

Risk Factors

Age over 50 years (especially 70-75)
Female sex (3:1 to 4:1)
Caucasian ancestry (especially Northern European)
Family history of GCA or polymyalgia rheumatica
Polymyalgia rheumatica
HLA-DRB1*04 alleles
Smoking history
Prior infections (varicella zoster virus implicated)
Atherosclerosis (synergistic risk)
Hypertension
Diabetes mellitus (paradoxically lower risk)
Recent weight loss
Symptoms of polymyalgia rheumatica
Previous AAION in fellow eye
Untreated or inadequately treated GCA
Delay in corticosteroid initiation
ESR markedly elevated
CRP markedly elevated
Low platelet count or anemia (paradoxical sometimes)
Female smokers

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Sudden, painless severe unilateral vision loss
  • Patient over 50 years with new severe headache
  • Jaw claudication
  • Scalp tenderness
  • Diplopia in elderly patient
  • Polymyalgia rheumatica with new ocular symptoms
  • Constitutional symptoms in elderly with vision changes
  • Elevated ESR or CRP in elderly with headache
  • Optic disc edema in elderly patient (urgent)
  • Cranial neuropathy in elderly
  • Stroke or transient ischemic attack in elderly with constitutional symptoms
  • EMERGENCY: any suspicion of GCA requires immediate evaluation

Treatment Methods

01
EMERGENCY immediate ophthalmic and rheumatologic evaluation (vision-threatening, contralateral risk within hours-days)
02
Comprehensive history including jaw claudication, scalp tenderness, headache, polymyalgia, constitutional symptoms
03
Detailed ophthalmic examination including dilated fundus examination
04
Visual field testing
05
Urgent ESR (often >50, frequently >80), CRP (markedly elevated), CBC (anemia, thrombocytosis)
06
Liver function tests, complete metabolic panel, alkaline phosphatase
07
Vascular ultrasound of temporal and axillary arteries (halo sign, compression sign)
08
MRI of cranial vessels, MR angiography (intracranial vessel involvement)
09
PET-CT for large vessel involvement (aorta, branches)
10
Temporal artery biopsy (gold standard) with adequate sample length (1-2 cm), bilateral if first negative
11
Histopathology showing granulomatous inflammation, giant cells, intimal hyperplasia, internal elastic lamina disruption
12
DO NOT DELAY corticosteroids for biopsy
13
Oral prednisone 1 mg/kg/day (typical 60-80 mg) immediately on suspicion
14
IV methylprednisolone pulse 500-1000 mg daily for 3 days for severe vision loss or threatened contralateral involvement
15
Tocilizumab (IL-6 receptor blocker) subcutaneously 162 mg weekly added for relapse prevention and corticosteroid sparing
16
Methotrexate as alternative steroid-sparing agent
17
Gradual prednisone taper over 12-18 months as guided by clinical response and inflammatory markers
18
Prophylaxis for corticosteroid-related complications: bone (calcium, vitamin D, bisphosphonates), gastric (PPI), Pneumocystis (TMP-SMX), glucose monitoring
19
Aspirin 81 mg daily often added (controversial, may reduce ischemic events)
20
Treat hypertension, hyperlipidemia, diabetes
21
Bone density monitoring
22
Aortic aneurysm surveillance with annual chest and abdominal imaging
23
Multidisciplinary care: ophthalmology, rheumatology, neurology, vascular medicine
24
Long-term follow-up with regular clinical assessment and inflammatory markers
25
Patient education on recurrence symptoms and importance of compliance
26
Monitor for relapse during taper

Which Department to Visit?

You can visit our Göz Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Göz Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.